trastuzumab,tucatinib,dabrafenib,rucaparib,trametinib,fulvestrant
novartis,seagen,clovis
['roar', 'roar,basket', 'dabrafenib', 'trametinib', 'basket trial']
 will be presenting some of the data from the roar basket trial that led to tissue agnostic approval soon dabrafenib plus trametinib in brafv600e-mutated rare cancers: phase 2 roar trial #asco23 
Chief, Early-Phase Drug Development|@SarahCannonDocs
#Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.